Dr Anthony Gordon

Dr Gordon is a Clinical Senior Lecturer and Consultant in Critical Care Medicine based at Charing Cross Hospital.

He received his medical degree from St Bartholomew’s Medical School in 1993 and then undertook his postgraduate medical training across the North Thames regions with an additional year spent at The Royal North Shore Hospital in Sydney, Australia. He was awarded the Fellowship of the Royal College of Anaesthetists in 1999 and returned to Barts to obtain his research doctorate examining genetic susceptibility in sepsis.

Having obtained a dual CCST in Anaesthesia and Intensive Care Medicine he was awarded the Intensive Care Society visiting fellowship in 2005 and spent two years in Vancouver at St Paul’s Hospital, University of British Columbia as a post-doctorate fellow. During this time he also worked as the Director of Medical Development of a university spin-out company developing pharmacogenetic tests for use in the ICU.

Dr Gordon returned to the Imperial AHSC in November 2007. He is currently a recipient of a Clinician Scientist Fellowship award from the National Institute for Health Research.

His research is focused on clinical and translational studies in sepsis. Particularly

• He is Chief investigator on a multi-centre study studying early vasopressin use in septic shock and interaction with corticosteroids (VANISH trial).

• He is a member of the management committee of the UK Critical Care Genomics group. This multi-disciplinary group brings together ICU clinicians, infectious diseases experts, geneticists and bio-statisticians to study the effects of genetic polymorphisms on the progression and outcome of severe sepsis. The GAinS study (Genomics Advances in Sepsis) has recruited more than 1000 patients with sepsis admitted to the ICU.